Vanda Pharmaceuticals Inc has a consensus price target of $11.5 based on the ratings of 2 analysts. The high is $12 issued by Jefferies on February 25, 2022. The low is $11 issued by Cantor Fitzgerald on July 11, 2024. The 2 most-recent analyst ratings were released by Cantor Fitzgerald and Jefferies on July 11, 2024 and February 25, 2022, respectively. With an average price target of $11.5 between Cantor Fitzgerald and Jefferies, there's an implied 86.39% upside for Vanda Pharmaceuticals Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/11/2024 | Buy Now | 78.28% | Cantor Fitzgerald | Charles Duncan | → $11 | Initiates | → Overweight | Get Alert |
02/25/2022 | Buy Now | 94.49% | Jefferies | Chris Howerton | $24 → $12 | Downgrade | Buy → Hold | Get Alert |
The latest price target for Vanda Pharma (NASDAQ:VNDA) was reported by Cantor Fitzgerald on July 11, 2024. The analyst firm set a price target for $11.00 expecting VNDA to rise to within 12 months (a possible 78.28% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Vanda Pharma (NASDAQ:VNDA) was provided by Cantor Fitzgerald, and Vanda Pharma initiated their overweight rating.
There is no last upgrade for Vanda Pharma
The last downgrade for Vanda Pharmaceuticals Inc happened on February 25, 2022 when Jefferies changed their price target from $24 to $12 for Vanda Pharmaceuticals Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vanda Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vanda Pharma was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
While ratings are subjective and will change, the latest Vanda Pharma (VNDA) rating was a initiated with a price target of $0.00 to $11.00. The current price Vanda Pharma (VNDA) is trading at is $6.17, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.